TriVascular Merger (Tables)

9 Months Ended

Sep. 30, 2016

Summary of Purchase Consideration Given in Acquisition

The total purchase consideration given related to the acquisition follows:



Cash consideration	$	84,634
Common stock consideration	100,812
Fair value of assumed TriVascular stock warrants	44
Total purchase consideration	$	185,490

Summary of Allocation of Purchase Consideration

The following presents the preliminary allocation of the purchase consideration to the assets acquired and liabilities assumed on February 3, 2016 (in thousands):



Cash and cash equivalents	$	24,012
Short-term investments	3,008
Accounts receivable	5,593
Inventories	17,765
Prepaid expenses and other current assets	1,895
Property and equipment	3,152
Intangible assets	46,200
Other assets	317
Accounts payable	(2,214		)
Accrued liabilities and other	(6,367		)
Notes payable	(61		)
Net assets acquired	$	93,300
Goodwill	$	92,190
Total preliminary purchase consideration	$	185,490

Schedule of Carrying Amount of Goodwill

The changes in the carrying amount of goodwill for the nine months ended September 30, 2016 are as follows (in thousands):



Balance at January 1, 2016	28,685
Goodwill acquired from the Merger	92,190
Foreign currency translation adjustment	42
Balance at September 30, 2016	$	120,917

Summary of Pro Forma Financial Information of Acquisition

The pro forma amounts do not purport to be indicative of the results that would have actually been obtained if the merger had occurred as of January 1, 2015 or that may be obtained in the future, and do not reflect future synergies, integration costs, or other such costs or savings.



	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2016			2015			2016			2015
Pro forma net sales	$	52,122		$	47,686		$	148,133		$	141,593
Pro forma net loss from continuing operations	(14,941		)	(25,639		)	(127,026		)	(83,056		)
Pro forma basic and diluted net loss per share	$	(0.18	)	$	(0.31	)	$	(1.55	)	$	(1.02	)